Abstract
We thank Ceppi and coauthors (1) for their comments on our recent paper on the identification of a miRNA-based signature predicting early relapse/progression in ovarian cancer patients (2). Epithelial ovarian cancer (EOC) is still the commonest cause of gynecological cancer-related death mainly due to the difficult early diagnosis and to the high frequency of patients eventually developing an incurable state of platinum-resistant disease (3). The selection of patients at higher risk of relapse is therefore an urgent need to improve the design of tailored therapies.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
